Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 28 | 27 | −1 |
| Shares | 20.1M | 20.0M | −192.9K (−1.0%) |
| Value | $110.8M | $113.9M | +$3.13M (+2.8%) |
New holders (2)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eversept Partners, LP | 113,597 | $648.6K | 0.05% |
| Citadel Advisors LLC | 10,466 | $60.0K | 0.00% |
Sold out (3)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Advisers, LP | 35,600 | $196.0K |
| Two Sigma Investments, LP | 16,235 | $89.0K |
| UBS Group AG | 483 | $3.00K |